Robert Schultz
Corporate Officer/Principal at SATSUMA PHARMACEUTICALS, INC.
Profile
Robert Schultz is currently the Vice President & Head-CMC at Satsuma Pharmaceuticals, Inc. Prior to this, he worked at Pearl Therapeutics, Inc. as the Senior Director-Product Development from 2012 to 2017.
He also worked as a Principal at Muro Corp., KOS*USA, Inc., and GlaxoSmithKline (New Jersey).
Mr. Schultz completed his undergraduate degree at Dartmouth College.
Robert Schultz active positions
Companies | Position | Start |
---|---|---|
SATSUMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2017 |
Former positions of Robert Schultz
Companies | Position | End |
---|---|---|
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01/07/2017 |
GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | - |
KOS*USA, Inc.
KOS*USA, Inc. Apparel/FootwearConsumer Non-Durables KOS*USA, Inc. manufactures and distributes fitness apparel. It supplies tops, bodysuit, bottoms, and prints to gyms, exclusive spas, specialty stores, and boutiques. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
MURO CORPORATION | Corporate Officer/Principal | - |
Training of Robert Schultz
Dartmouth College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MURO CORPORATION | Producer Manufacturing |
Private companies | 4 |
---|---|
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
KOS*USA, Inc.
KOS*USA, Inc. Apparel/FootwearConsumer Non-Durables KOS*USA, Inc. manufactures and distributes fitness apparel. It supplies tops, bodysuit, bottoms, and prints to gyms, exclusive spas, specialty stores, and boutiques. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Consumer Non-Durables |
GlaxoSmithKline (New Jersey) | |
Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Robert Schultz